Humana Inc. Files Q3 2024 10-Q Report

TL;DR

Humana's Q3 2024 10-Q is in. Check financials.

AI Summary

Humana Inc. filed its 10-Q for the period ending September 30, 2024. The filing covers the third quarter of 2024 and provides financial updates for the company. Key financial data and operational details are presented for the reporting period.

Why It Matters

This filing provides investors and analysts with the latest financial performance and operational status of Humana Inc., a major health insurance provider.

Risk Assessment

Risk Level: low — This is a standard quarterly financial filing with no immediate red flags.

Key Players & Entities

• HUMANA INC (company) — Filer
• 0000049071 (company) — Central Index Key
• 20240930 (date) — Period of Report
• 20241030 (date) — Filing Date
• 500 W MAIN ST (address) — Business Address
• LOUISVILLE (city) — Business Address City
• KY (state) — Business Address State
• 40202 (zip_code) — Business Address Zip
• 5025801000 (phone_number) — Business Phone

FAQ

Key Financial Figures

• $0.16 — ange on which registered Common stock, $0.16 2/3 par value HUM New York Stock Exchan

Filing Documents

• hum-20240930.htm (10-Q) — 2168KB
• hum-20240930xex31x1.htm (EX-31.1) — 9KB
• hum-20240930xex31x2.htm (EX-31.2) — 10KB
• hum-20240930xex32.htm (EX-32) — 6KB
• 0000049071-24-000055.txt ( ) — 10858KB
• hum-20240930.xsd (EX-101.SCH) — 54KB
• hum-20240930_cal.xml (EX-101.CAL) — 95KB
• hum-20240930_def.xml (EX-101.DEF) — 272KB
• hum-20240930_lab.xml (EX-101.LAB) — 740KB
• hum-20240930_pre.xml (EX-101.PRE) — 507KB
• hum-20240930_htm.xml (XML) — 2276KB

: Financial Information

Part I: Financial Information

Financial Statements

Item 1. Financial Statements Condensed Consolidated Balance Sheets (Unaudited) at September 30, 2024 and December 31, 2023 3 Condensed Consolidated Statements of Income (Unaudited) for the three and nine months ended September 30, 2024 and 2023 4 Condensed Consolidated Statements of Comprehensive Income (Unaudited) for the three and nine months ended September 30, 2024 and 2023 5 Condensed Consolidated Statements of Stockholders' Equity (Unaudited) for the three and nine months ended September 30, 2024 and 2023 6 Condensed Consolidated Statements of Cash Flows (Unaudited) for the nine months ended September 30, 2024 and 2023 8 Notes to Condensed Consolidated Financial Statements (Unaudited) 10

Management's Discussion and Analysis of Financial Condition and Results of Operations 36

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations 36

Quantitative and Qualitative Disclosures about Market Risk 52

Item 3. Quantitative and Qualitative Disclosures about Market Risk 52

Controls and Procedures 52

Item 4. Controls and Procedures 52

: Other Information

Part II: Other Information

Legal Proceedings 53

Item 1. Legal Proceedings 53

Risk Factors 53

Item 1A. Risk Factors 53

Unregistered Sales of Equity Securities and Use of Proceeds 53

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 53

Defaults Upon Senior Securities 54

Item 3. Defaults Upon Senior Securities 54

Mine Safety Disclosures 54

Item 4. Mine Safety Disclosures 54

Other Information 54

Item 5. Other Information 54

Exhibits 55

Item 6. Exhibits 55 Signatures 56 Certifications Humana Inc. CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) September 30, 2024 December 31, 2023 (in millions, except share amounts) ASSETS Current assets: Cash and cash equivalents $ 5,116 $ 4,694 Investment securities 19,033 16,626 Receivables, net of allowances of $ 93 in 2024 and $ 88 in 2023 2,144 2,035 Other current assets 6,633 6,631 Total current assets 32,926 29,986 Property and equipment, net 2,693 3,030 Long-term investment securities 400 382 Equity method investments 729 740 Goodwill 9,590 9,550 Other long-term assets 3,669 3,377 Total assets $ 50,007 $ 47,065 LIABILITIES AND STOCKHOLDERS' EQUITY Current liabilities: Benefits payable $ 11,125 $ 10,241 Trade accounts payable and accrued expenses 5,915 6,569 Book overdraft 356 353 Unearned revenues 195 266 Short-term debt 1,136 1,443 Total current liabilities 18,727 18,872 Long-term debt 11,886 10,213 Other long-term liabilities 1,770 1,662 Total liabilities 32,383 30,747 Commitments and Contingencies (Note 13) Stockholders' equity: Preferred stock, $ 1 par; 10,000,000 shares authorized; none issued — — Common stock, $0.16 2/3 par; 300,000,000 shares authorized; 198,718,810 shares issued at September 30, 2024 and 198,690,082 shares issued at December 31, 2023 33 33 Capital in excess of par value 3,471 3,346 Retained earnings 29,118 27,540 Accumulated other comprehensive loss ( 653 ) ( 999 ) Treasury stock, at cost, 78,307,467 shares at September 30, 2024 and 76,465,862 shares at December 31, 2023 ( 14,404 ) ( 13,658 ) Total stockholders' equity 17,565 16,262 Noncontrolling interests 59 56 Total equity 17,624 16,318 Total liabilities and equity $ 50,007 $ 47,065 See accompanying notes to condensed consolidated financial statements. 3 Humana Inc. CONDENSED CONSOLIDATED STATEMENTS OF INCOME (Unaudited) Three months ended September 30, Nine months ended September 30, 2024 2023 2024 2023 (in

View Full Filing

View this 10-Q filing on SEC EDGAR